116 related articles for article (PubMed ID: 1299719)
61. [The treatment of leprosy in 2003].
Flageul B
Acta Leprol; 2003; 12(3):105-6. PubMed ID: 15040699
[No Abstract] [Full Text] [Related]
62. A double-blind controlled clinical trial to assess the role of anti-histamines in the treatment of multi-bacillary leprosy.
Thomas A; Nagarajan M; Chandrasekaran V; Hari L; Somasundaram PR; Prabhakar R; Kumar A; Bhatia VN; Roy RG
Indian J Lepr; 1988 Oct; 60(4):499-505. PubMed ID: 3075630
[TBL] [Abstract][Full Text] [Related]
63. [Autoantibodies in lepromatous leprosy].
Graninger W; Hollenstein U; Dudeck U; Kremsner PG; Saylan T
Wien Klin Wochenschr; 1991; 103(9):268-70. PubMed ID: 2068818
[TBL] [Abstract][Full Text] [Related]
64. Use of "Novolep", a by-product of D.D.S., for the treatment of trophic ulcers (planter) in leprosy.
Mahapatra SB
Indian J Dermatol; 1975 Oct; 21(1):22-4. PubMed ID: 1234880
[No Abstract] [Full Text] [Related]
65. Minocycline-induced hyperpigmentation in leprosy.
Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
[TBL] [Abstract][Full Text] [Related]
66. [The frequency of the appearance of perforating foot ulcers in patients with Hansen's disease as a function of treatment with disulone alone or with polychemotherapy].
Mane I; Grauwin MY; Cartel JL
Acta Leprol; 1995; 9(3):127-31. PubMed ID: 7631583
[TBL] [Abstract][Full Text] [Related]
67. [Immuno-allergic accidents with rifamipcin].
Flageul B; Wagner L; Cottenot F
Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
[TBL] [Abstract][Full Text] [Related]
68. Single dose multidrug therapy for single lesion paucibacillary leprosy.
Kars HK
Indian J Lepr; 1998; 70(2):214-5; author reply 219-21. PubMed ID: 9724859
[No Abstract] [Full Text] [Related]
69. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
Mathew D; Kishore BN; Shwethadri GK; Sukumar ; Shetty NJ
Indian J Lepr; 2004; 76(1):11-8. PubMed ID: 15527055
[TBL] [Abstract][Full Text] [Related]
70. [Recurrent lepromatous leprosy in conventional triple therapy: value of the rifampicin-ofloxacin combination].
Marlier S; Carsuzaa F; De Jaureguiberry JP; Galzin M; Carloz E; Carli P; Chagnon A
Med Trop (Mars); 1995; 55(2):182. PubMed ID: 7565004
[No Abstract] [Full Text] [Related]
71. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
72. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
Colin M; de Montaigne E
Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
[TBL] [Abstract][Full Text] [Related]
73. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
74. Feasibility of multidrug therapy (MDT) in Hansen's disease in an urban population--Curupaiti State Hospital, Rio de Janeiro, Brazil.
Andrade VL; Marques AB; da Cunha LH; Avelleira JR
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):435-40. PubMed ID: 3655459
[TBL] [Abstract][Full Text] [Related]
75. Serological monitoring of the response to chemotherapy in leprosy patients.
Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
[TBL] [Abstract][Full Text] [Related]
76. Persister studies in leprosy patients after multi-drug treatment.
Gupta UD; Katoch K; Singh HB; Natrajan M; Katoch VM
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):100-4. PubMed ID: 16830652
[TBL] [Abstract][Full Text] [Related]
77. Single dose multidrug therapy for single lesion paucibacillry leprosy.
Salafia A
Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
[No Abstract] [Full Text] [Related]
78. Involvement of genitofemoral nerve with genital lesions in lepromatous leprosy.
Agrawal SK; Singal A; Pandhi D; Oberoi S
Indian J Lepr; 2004; 76(1):71-7. PubMed ID: 15527060
[TBL] [Abstract][Full Text] [Related]
79. Lepromatous leprosy reversal reaction.
Chirch LM; Jimenez VE
Lancet Infect Dis; 2005 Jan; 5(1):64. PubMed ID: 15620563
[No Abstract] [Full Text] [Related]
80. Reactions in leprosy. A study of 250 patients in a multidrug therapy project, Baroda District, Gujarat, India.
Chopra NK; Agrawal JS; Pandya PG
Int J Dermatol; 1990 Sep; 29(7):490-3. PubMed ID: 2228376
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
